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Surgical TechniquesDISCUSSION
PV stenosis appears frequently in neonates or infants
with congenital heart disease such as total anomalous pul-
monary venous connection. PV stenosis can be repaired us-
ing several surgical procedures, including a sutureless
technique,1,2 patchplasty,3 excision of the stenosis,3 and re-
implantation of the PV with direct anastomosis.4 The su-
tureless technique has evolved as a method to treat
patients with recurrent PV stenosis developing after repair
of total anomalous pulmonary venous connection. This
technique requires no direct suturing of the PVs, enabling
aggressive resection of the anterior wall of the segmental
PV. Thus, the PV confluence can be created as wide as pos-
sible, even in complicated cases such as redo procedures.
Additionally, oblique incision of the LAAp is key to creat-
ing a large atriopericardial anastomosis.
Although various congenital cases have been docu-
mented, to the best of our knowledge, only 1 adult case
has been previously reported.3 In a 43-year-old man with
PV stenosis caused by idiopathic mediastinal fibrosis, peri-
cardial patchplasty was performed for repair.3 After that re-
port, we used conventional patchplasty for the first time.
Subsequently, the sutureless technique was indicated for re-
current PV stenosis. However, a recent study reported that
no significant difference could be found in the primary out-
comes between the primary sutureless technique and con-
ventional patchplasty in patients with a total anomalous
pulmonary venous connection.1 Accordingly, our strategy
was considered reasonable and proper for the present
patient.
Currently, more than 40,000 cases of catheter ablation are
attempted each year in the United States.5 PV stenosis in-
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or the potential need for surgical intervention.5 However,
once PVocclusive disease has been established in neonates
or infants, no matter how effective, the surgical relief could
short term.1 These unfortunate patients are plagued by re-
current PV stenosis that eventually translates into mortality.1
In adult patients with PV stenosis, balloon angioplasty is
recommended as the initial treatment, with stenting as the
second choice. Finally, surgical correction would be indi-
cated. Although the sutureless technique was effective in re-
lieving complex forms of PV stenosis as in neonates and
infants, it should be cautioned that the sutureless technique
also has a known incidence of recurrent PV stenosis.1CONCLUSIONS
A successful surgical case of recurrent PV stenosis after
catheter ablation in an adult is reported. The sutureless tech-
nique is effective in preventing reactive hyperplasia of the
intima over the connection between the left atrium and
the PVs, especially for redo cases after failure of conven-
tional patchplasty.
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thoracic endovascular aortic repair followed by definitive open aortic
and esophageal reconstructionPrashanth Vallabhajosyula, MD, MS, Caroline Komlo, BS, Tyler Wallen, DO, and Wilson Y. Szeto, MD,
Philadelphia, PaAortoesophageal fistula (AEF) is a rare complication, and
is generally fatal without surgical intervention.1 Primary
causes for AEF formation include foreign body ingestion,
ruptured thoracic aortic aneurysms, endograft stenting
of the thoracic aorta, advanced esophageal cancer, and
surgical procedures involving the esophagus.1 Even
though there are reports of thoracic endovascular stenting
for the treatment of aortoesophageal fistula with early
success,1,2 late failure and mortality is common. Thegery c November 2012
FIGURE 1. Preoperative and post-thoracic endovascular aneurysm repair (TEVAR) imaging, and intraoperative findings. A, Reconstructed image from
a contrast computed tomography scan performed at initial presentation shows the thoracic aortic pseudoaneurysm with surrounding phlegmon. B, After
emergent TEVAR performed for hemodynamic stabilization, contrast computed tomography scan 10 days later showed the endovascular stent with peri-
aortic air and phlegmon. C, Post-TEVAR, the stabilized patient was taken back to the operating for a definitive repair. Intraoperatively, the endovascular
stent was seen immersed in a mediastinal collection of pus. D, The endovascular stent and the involved thoracic aorta were resected, and an interposition
homograft was placed.
Surgical Techniquesgeneral consensus challenges the concept of deployment
of an endograft prosthesis in the setting of an infected
field. We report a case of AEF with gross mediastinal
contamination treated in a planned 2-stage approach:
initial endovascular stenting of the thoracic aorta as
a bridge for patient stabilization, followed by definitive
open surgical repair (ie, replacement of the endograft
with an aortic homograft, esophageal repair, and wide me-
diastinal drainage).
CLINICAL SUMMARY
A 56-year-old woman with a history of achalasia pre-
sented to the emergency department in septic shock. She
had a week-long history of fever, back pain, and leukocy-
tosis. Two weeks prior, she had undergone upper endos-
copy with botulinum injections for achalasia and
experienced an episode of hematemesis. In the emergency
department, esophagogram failed to show an active AEF,
but a computed tomography scan showed a boggy esoph-
agus, mediastinal phlegmon with air, and a leaking tho-
racic aortic pseudoaneurysm (Figure 1, A). Given her
hemodynamic instability and sepsis, the decision was to
proceed with a temporizing endovascular procedure, withThe Journal of Thoracic and Cara subsequent staged definitive open repair. The patient
was emergently taken to the operating room for thoracic
endovascular aneurysm repair (TEVAR) with a Medtronic
Talent (Medtronic Inc, Minneapolis, Minn) proximal main
device (Figure 1, B). Completion angiogram demonstrated
no evidence of an endoleak, and no filling of the sacular
pseudoaneurysm.
The patient recovered in the intensive care unit during the
following week. She was empirically started on broad spec-
trum antibiotics, including antifungal coverage (eg, vanco-
mycin, cefepime, and fluconazole). Repeat imaging showed
a mediastinal abscess with air around the aortic endograft
(Figure 1, B). After medical optimization and correction
of her septic shock physiology, she was taken back to the
operating room for definitive treatment 12 days later. En-
doscopy failed to show AEF, although a focal area of in-
flammation was noted posteriorly. Right video assisted
thoracoscopic surgery was performed to widely drain the
mediastinum. Next, a left thoracoabdominal incision was
made. The mediastinal abscess was identified at the level
of the diaphragm and debrided (Figure 1,C). The esophagus
was inspected and found to be intact. Her achalasia was de-
finitively addressed with a myotomyþDor fundoplicationdiovascular Surgery c Volume 144, Number 5 1267
FIGURE 2. Reconstructed computed tomography scan performed at
2-year follow-up showed an intact aortic repair without any pseudoaneur-
ysm formation.
Surgical Techniquesalong with jejunostomy tube placement. For the aortic de-
bridement and reconstruction, left atrium–femoral artery
bypass was utilized. (Figure 1,D). Aorta and infected endo-
vascular graft were removed, and a cryopreserved homo-
graft was sewn into place in standard fashion (Figure 1,
D). Finally, an omental flap was placed.
The patient recovered well from the procedure and was
discharged from the hospital. Antibiotics were continued
for 10 days postoperatively, and then stopped. At 2-year
follow-up, computed tomography scan demonstrated
a well-healed posterior mediastinum with an intact aortic
repair (Figure 2). Her achalasia symptoms also improved,
with significant weight gain and no further dysphagia.
DISCUSSION
The role of endovascular stent grafting in definitive treat-
ment of AEF remains uncertain. Late infection with rupture
and associated mortality rates are high when TEVAR is
used as a sole therapeutic strategy.3,4 Per 1 retrospective
review,3 4 of 5 patients treated with TEVAR alone as acute
management of AEF died. Of these, 3 patients required ad-
ditional esophageal surgery later, of which only 1 survived.
In patients with AEF presenting with hematemesis,
shock, or sepsis, emergent open surgical repair may also
be associated with high mortality. For these patients, we
prefer a strategy of a temporizing endovascular procedure
to stabilize the patient in extremis, and upon recovery,1268 The Journal of Thoracic and Cardiovascular Sura definitive open surgical repair at a later time. In a study
by Topel et al,5 a staged approach to the treatment of AEF
was associated with better outcomes than TEVAR alone.
In 2 patients presenting with AEF, emergent TEVAR was
utilized for patient stabilization, and an open aortic repair
with homograft and esophageal repair was performed later.
In 2 other patients undergoing TEVAR alone, mortality was
100%. Although those cases represent a very small series,
the use of TEVAR as a bridge for later definitive open treat-
ment may be a prudent strategy in the treatment of acute
AEF.
The presented case attests to the potential significance
of such a staged treatment strategy. Initial TEVAR for pa-
tient stabilization in acute AEF would ensure hemody-
namic stability and prevent the morbidity and mortality
associated with an open repair in such conditions. Clearly,
TEVAR does not address the underlying esophageal prob-
lem, the fistula, and the associated mediastinal infection.
In fact, it introduces prosthetic material into a potentially
contaminated field. Therefore, a planned second-stage de-
finitive open operation treating the esophageal condition,
replacing the prosthetic endograft with a homograft, along
with wide mediastinal drainage, has become our preferred
therapeutic strategy for the treatment of patients with AEF.
The longevity of the homograft in the descending aortic
position is not clear, although we believe it will likely
last her lifetime. Literature on aortic homografts typically
looked at aortic root replacement. In this situation, homo-
graft failure occured secondary to valve failure. Homo-
graft calcification is a known long-term consequence,
but in the descending thoracic aortic position, it would
not cause any symptoms.References
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